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Commentary
Computational toxicology is the applica-
tion of high-powered computing to man-
age and detect patterns and interactions in 
large biological and chemical data sets. 
Computational toxicology takes advantage of 
three significant technological breakthroughs: 
high-  information-content data streams (e.g., 
from micro  array or in vitro high-throughput 
screening experiments), novel biostatistical 
methods, and the computational power to 
analyze these data (Judson et al. 2009; Nigsch 
et al. 2009). Life scientists are acutely aware 
of the technologies that produce large data 
sets, but the steady increase in computational 
power is of equal importance in supporting 
discoveries at a systems level in understanding 
the interaction of environmental agents with 
biological systems, and how those interactions 
may produce adverse consequences. Perhaps 
because computer technology is so much a 
part of our daily lives, we have overlooked 
the fact that it is becoming a crucial element 
in the next great leap in our understanding of 
how exogenous agents affect living systems. 
In this commentary we reflect on the out-
comes of the National Academies’ Standing 
Committee on Use of Emerging Science for 
Environmental Health Decisions meeting on 
“Computational Toxicology: From Data to 
Analyses to Applications,” sponsored by the 
National Institute of Environmental Health 
Sciences (National Academy of Sciences 
2010). The overarching objectives of this 
meeting were to review the state of the art in 
computational toxicology and the practical 
applications of the new science and to provide 
focus to the field.
Toxicology: A Science in 
Transition
Toxicology as a modern science has been 
active and productive in two complementary 
areas (Andersen and Krewski 2009). The first 
is the largely descriptive process of determin-
ing the effects of a large number of chemicals 
of commercial or environmental importance 
on the function of various organ systems, at 
different life stages, using animal models. This 
exercise has created a large knowledge base of 
the toxicologic effects of chemicals, usually at 
the organ or organismal level. Recent efforts 
to organize this type of information into a 
large, searchable database [Toxicity Reference 
Database (ToxRefDB); U.S. Environmental 
Protection Agency (EPA) 2010a] have yielded 
some interesting insights (Martin et al. 2009). 
The second area is the investigative process 
of identifying the mode of action of many 
of these agents, usually at the molecular or 
cellular level, which uses both in vivo and 
in vitro model systems (Harrill and Rusyn 
2008). This latter path of investigation has 
been important in identifying a number of 
significant targets for toxicants. These two 
parallel tracks of research have been important 
in constructing a conceptual framework for 
toxicology that can be used to support risk 
assessment and public health decisions; how-
ever, these have a few significant drawbacks. 
One of the most important drawbacks is that 
both descriptive and mechanistic toxicology 
are labor and resource intensive and are too 
inefficient to comprehensively evaluate more 
than a fraction of the chemicals in commerce 
and the environment (Andersen and Krewski 
2009). A proposed solution to this problem 
is to develop more rapid screening methods 
based on a mechanistic understanding of tox-
icity; however, mechanistic research has been 
reductionist in nature and may not be fully 
capable of characterizing the full spectrum of 
targets for agents that affect multiple systems 
at roughly the same concentration and/or have 
pleiotropic effects. There is a need, through 
a combination of high-information-content 
biology and computational modeling, to   
sew together the isolated threads of the reduc-
tionist mechanistic research into a framework 
that is predictive of the behavior of an intact 
biological system.
Interdisciplinary Input into 
Toxicology
The field of computational toxicology is a 
synthesis of toxicology, biostatistics, systems 
biology, computer science, and many other rel-
evant disciplines. Advances in computer-based 
approaches to modeling biological systems at 
different scales are becoming some of the key 
elements in facilitating the development of a 
predictive capacity for estimating outcomes 
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reflects on the presentations and roundtable discussions from the meeting that were designed to 
review the state of the art in the field and the practical applications of the new science and to pro-
vide focus to the field.
oBjectives: The meeting considered two topics: the emerging data streams amenable to computa-
tional modeling and data mining, and the emerging data analysis and modeling tools.
discussion: Computational toxicology is a subdiscipline of toxicology that aims to use the math-
ematical, statistical, modeling, and computer science tools to better understand the mechanisms 
through which a given chemical induces harm and, ultimately, to be able to predict adverse effects 
of the toxicants on human health and/or the environment. The participants stressed the importance 
of computational toxicology to the future of environmental health sciences and regulatory decisions 
in public health; however, many challenges remain to be addressed before the findings from high-
throughput screens and in silico models may be considered sufficiently robust and informative.
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to assess human toxicity are now needed, and technological breakthroughs are empowering the field 
of toxicity assessment. Even though the application of computational toxicology to environmental 
health decisions requires additional efforts, the merger of the power of computers with biological 
information is poised to deliver new tools and knowledge.
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or risk associated with exposure of organ-
isms to drugs and environmental toxicants. 
Computational toxicology holds the key for 
effectively using high-dimensional data streams 
from computational chemistry, molecu  lar biol-
ogy, and systems biology. Importantly, the sci-
ence of computational toxicology is reaching 
beyond basic research into the field of regula-
tory decision making and environmental health 
protection (Kavlock et al. 2009). The develop-
ment of improved linkages across the source-
to-outcome continuum—including the areas 
of chemical transformation and metabolism, 
better diagnostic/prognostic molecular mark-
ers, improved dose metrics, characterization of 
toxicity pathways, systems biology approaches, 
modeling frameworks, and uncertainty 
  analysis—is a major objective of the science of 
computational toxicology. Equally important 
is its promise to provide improved predictive 
models for hazard identification, including the 
areas of quantitative structure–activity rela-
tionships (QSARs) and other computational 
approaches; improved pollution prevention 
strategies; and high-throughput screening of 
chemicals for safety. Finally, a multidisciplinary 
approach such as computational toxicology 
is required to address the uncertainties in 
quantitative risk assessment in dose–response 
assessment, cross-species extrapolation, and 
chemical mixtures, and to better understand 
the potential for chemicals to be human health 
and   environmental hazards.
New Data Sources: New 
Challenges and Opportunities
A number of data streams can be used to 
populate computational toxicology models 
(Judson et al. 2008). Toxicogenomics, pro-
teomics, and metabolomics generate very 
large, information-rich data sets that are fod-
der for computational methods, although they 
each provide different information (Harrill 
and Rusyn 2008). These approaches provide a 
comprehensive assessment of gene expression, 
protein expression, or metabolite generation 
in a particular tissue, organ, or organism in 
response to a perturbation. This information 
has also been used as a way to identify path-
ways of response, at the molecular level, that 
are responsible for toxic outcomes.
High-throughput screening is another sig-
nificant source of toxicologic information. In 
high-throughput screening, simple assays—
such as receptor binding assays, enzymatic 
assays, or reporter gene assays—are conducted 
in multiwell-plate format in which hundreds 
or thousands of chemicals can be tested at 
once to query their effect on a single biologi-
cal response (Houck and Kavlock 2008). This 
type of screening has been optimized by the 
pharmaceutical industry to evaluate extremely 
large combinatorial chemistry libraries to iden-
tify compounds with high activity for a specific 
molecular target. In toxicology, however, the 
application of the high-throughput screen-
ing is quite different: The ultimate outcome 
is lack of activity for key toxicity targets—a 
lack of activity that may ultimately be used 
as an indicator of lack of hazard or to assist 
in defining the mode of action. For example, 
the National Institutes of Health’s Chemical 
Genomics Center is conducting a large num-
ber of these high-throughput assays in parallel 
to investigate which biological processes are 
targets of environmental chemicals (Xia et al. 
2008), as part of the ToxCast (Dix et al. 2007) 
and Tox21 (Collins et al. 2008) research pro-
grams. This effort involves screening > 1,000 
chemicals, most of which also have a compre-
hensive in vivo data set, in several hundred 
in vitro assays that evaluate a specific aspect of 
toxicity. With all these data generated, com-
putational modeling of biological systems can 
now rely on sufficient input details and begin 
in silico reconstruction of normal functions 
and prediction of major disease states. Using 
network models of biological systems, scientists 
may gain a better understanding of how cells 
sense their environment and respond to envi-
ronmental stimuli. In turn, this understanding 
can help unravel complex relationships across 
biological systems and support a scientifically 
sound process of projecting human health risks 
posed by chemicals.
“Chemical Toxicology”: 
Using Molecular Features 
for Predicting Toxicity
The prediction of toxicologic activity based on 
chemical structure (QSARs) was among the 
first applications of computation in toxicol-
ogy. The first QSAR attempts were statistical 
in nature, based on the premise that toxicity 
could be correlated with certain molecular 
characteristics of the chemical agents that cause 
that particular kind of toxicity. These early 
models were limited in the number of param-
eters that could be modeled and tended not 
to be very predictive, especially for complex 
toxicities that can be produced through many 
different mechanisms of action, such as devel-
opmental toxicity or organ toxicity. Because 
these early models were not as successful or 
widely applicable as was hoped, the main-
stream toxicology community is now only 
guardedly optimistic that QSAR models will 
be able to play a major role in prediction of 
chemical hazard. This is unfortunate, because 
there have been a number of advances in mod-
eling chemical–biological interactions, based 
on a strong mechanistic understanding of tox-
icity, that are leading to improved structure–
activity relationship (SAR) and QSAR models.
The most accessible and transparent 
approaches to prediction based on chemical 
structure have been expert rule-based SAR 
models, supported by large relational databases 
of toxicologic information that can be searched 
by chemical structure and substructure to iden-
tify analogs that can be used to make inferences 
about the toxicity of a new chemical (Richard 
et al. 2006). DSSTox (Distributed Structure-
Searchable Toxicity; U.S. EPA 2010b) is 
one of these databases. It is a compilation of 
the toxicity data from a variety of sources in 
the peer-reviewed literature [e.g., TOXNET 
(National Library of Medicine 2010)] and gray 
literature [e.g., Toxic Substance Control Act 
Test Submission Database (TSCATS), and 
International Uniform Chemical Information 
Database (IUCLID5 2010)] literature that can 
be searched by chemical substructure. Expert-
driven rules and best judgment from experts 
in medicinal chemistry can be used to identify 
the appropriate search strategies and analogs 
(Snyder et al. 2004; Wu et al. 2010). Although 
SAR still requires the involvement of experts, 
it demonstrates the value of chemical struc-
ture–based approaches in predicting toxicity. 
The next step is to incorporate the mechanistic 
understanding of experts into computational 
models, which is the realm of the next gen-
eration QSARs. These QSAR models are based 
on a solid framework of knowledge about the 
mechanisms that cause particular aspects of 
toxicity and are therefore likely to be highly 
predictive. For example, it is clear that a neces-
sary chemical–biological interaction in chemi-
cal allergy is the covalent binding of the hapten 
to specific amino acid residues, and the relative 
potency of sensitizers is related to the speed 
and extent to which the binding takes place 
and this relationship can be modeled using 
QSAR (Gerberick et al. 2008).
Traditional QSAR models are developed 
based on chemical descriptors alone (Richard 
et al. 2006); however, the predictivity of most 
available toxicology-relevant QSAR models is 
quite limited, especially for in vivo toxicity end 
points (Zhu et al. 2008b). Historically, QSAR 
modeling in toxicology has been limited, in 
part, because of lack of mechanistically relevant 
biological data on hundreds of compounds. 
The recent availability of high-throughput and 
multidimensional (e.g., -omics) toxicity data 
on very large chemical libraries represents an 
intriguing avenue for further developments in 
computational toxicology via QSAR. Indeed, 
recent studies showed that the predictivity of 
QSAR models for in vivo toxicity is improved 
when in vitro testing results (i.e., biological 
descriptors) are combined with the traditional 
chemical descriptors (Zhu et al. 2008a).
Applications of Computational 
Toxicology to Regulatory 
Decision Making
High-throughput cell-based and cell-free 
screening technologies (Xia et al. 2008) that 
can be applied to screen hundreds of chemi-
cals in dozens of assays for the first time The computational toxicology challenge
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provide data that may be used for the toxi-
cologic evaluation of their potential human 
health hazard, especially when combined 
with the knowledge of the chemical struc-
ture, metabolism, and disposition. The U.S. 
EPA and other organizations are viewing such 
screening programs as the first step to priori-
tize agents for targeted in vivo and/or in vitro 
testing (Judson et al. 2009). Although the pri-
oritization process and hazard identification 
are important for the overall process of risk 
assessment, the in vitro data and computa-
tional predictions can be potentially useful in 
mode-of-action, dose–response, and exposure 
assessment and in understanding of the indi-
vidual variability in the population.
The management, analysis, and inter-
pretation of the new data now available for 
toxicologic assessment of safety require con-
siderable computational resources but are 
likely to provide a great deal of insight into 
the possible mode of action of the chemicals 
under evaluation, as well as the value of the 
individual assays in supporting predictions 
for new chemicals. Even the analyses of the 
in vivo data sets that have been digitized from 
the historical paper records (Knudsen et al. 
2009; Martin et al. 2009) have provided valu-
able insight into the strengths and weaknesses 
of the various animal models used to model 
potential human toxicity and into correlations 
between different manifestations of toxicity.
The modeling of complex data sets is 
helping to identify the key gene products 
that regulate biological activities that lead to 
toxicity. Many of the data for such modeling 
activities are from microarray experiments, 
along with proteomics and metabolomics. 
Toxicogenomics—the evaluation of all of the 
gene expression changes in a particular tar-
get tissue—has been particularly valuable in 
uncovering potential mechanisms of toxicity. 
Although some toxicants have highly specific 
targets, it is likely that most toxicants have the 
potential to interact weakly with a large num-
ber of targets, both complicating the process of 
defining how the toxicant produces its adverse 
effects and bringing into question whether all 
possible modes of action have been considered. 
Toxicogenomics addresses both questions. 
Analysis of these highly complex data sets is 
made possible through sophisticated compu-
tational methods that can elucidate concen-
tration- and time-response patterns (Thomas 
et al. 2007) that are suggestive of effects on 
specific pathways (rather than just individual 
genes). This not only supports generation of 
hypotheses about mode of action but also pro-
vides knowledge for science-informed extrapo-
lation for high to low dose and from animals 
to humans (Andersen et al. 2008).
Importantly, the dose-dependent transi-
tions in modes of action for toxicant-  mediated 
signaling, a phenomenon demonstrated for 
a number of toxicants (Naciff et al. 2005; 
Woods et al. 2007, 2009), call for the use of 
genomic, bioinformatic, and computational 
systems biology tools to understand differ-
ent qualitative behaviors across dose levels. 
Dose–response studies uncovering molecular 
signatures of genes and pathways combined 
with the new computational systems biology 
tools for so-called developmental networks 
(Alon 2007) can provide data for mechanistic 
dose–response models that can integrate sev-
eral areas in computational toxicology, infer 
low-dose behaviors, and assist in risk assess-
ment as well as hazard identification.
New screening methods can also identify 
molecular targets and transcriptional regulators 
of key toxicity pathways that associate with 
in vivo end points, data that can be used as 
toxicity pathway–based biomarkers and as an 
input for predictive modeling of in vivo toxicity 
(Martin et al. 2010). Computational model-
ing can be used to evaluate how different gene 
products believed to be critical for a particular 
process interact. For example, critical genes in 
somite formation in the vertebrate embryo are 
being identified (McMahon et al. 2008) and 
can be modeled (Swat et al. 2009) to demon-
strate the formation of somitic boundaries and 
positional information as somites are laid down 
on an anterior–posterior axis.
Physiologically based pharmacokinetic 
(PBPK) modeling is a methodology both 
for considering pharmacokinetic differences 
across species when estimating human risk 
from animal data and for evaluating the 
impact of pharmacokinetic variability on the 
dispersion of individual risks. Briefly, PBPK 
modeling attempts to describe the relationship 
between external measures of applied dose 
(e.g., amount administered or concentration 
in food, water, or air) and internal measures 
of delivered dose (e.g., amount metabolized 
or concentration in the tissue displaying the 
toxic response), using as realistic a description 
of mammalian physiology and biochemis-
try as is necessary and feasible (Clewell and 
Clewell 2008). PBPK modeling is an example 
of computational toxicology that has actually 
entered mainstream applications in risk assess-
ment; it can address a critical gap in in vitro–
to–in vivo extrapolations for relating results 
from improved in vitro models to real-world 
human exposure conditions and can assist in 
modeling dose–response behaviors in interac-
tions of chemicals with biological systems.
Although cell-based in vitro models are 
being used extensively in toxicology studies 
as a means to evaluate the mechanisms of 
toxicity or to identify interactions of target 
compounds with metabolizing enzymes and 
transporters, the focus is frequently on either 
primary or immortalized cells of unknown 
genetic background. Importantly, the avail-
ability of the large bank of publicly available 
densely genotyped cells lines for lymphoblasts 
(e.g., Centre d’Etude du Polymorphisme 
Humain and Coriell Institute for Medical 
Research) and for cancer (e.g., NCI-60 
panel; Developmental Therapeutics Program, 
National Cancer Institute, National Institutes 
of Health, Bethesda, MD) shows promise 
for in vitro screening that can appropriately 
consider the genetic variability in the popula-
tion (Welsh et al. 2009). Although not with-
out limitations, studies in genetically defined 
in vitro models may provide critical informa-
tion for science-based considerations for both 
intra- and interspecies uncertainty factors used 
in risk assessment.
Conclusions
The areas of promise for computational toxi-
cology were discussed by the scientists from 
the government regulatory agencies, non-
governmental organizations, academia, and 
industry at a September 2009 meeting titled 
“Computational Toxicology: From Data to 
Analyses to Applications,” convened by the 
National Academies’ Standing Committee on 
Use of Emerging Science for Environmental 
Health Decisions and sponsored by the 
National Institute of Environmental Health 
Sciences (National Academy of Sciences 2010). 
Applications of computational approaches 
to predictive toxicology will be important in 
prioritizing chemicals for further testing and 
in uncovering mechanistic information that 
is valuable in tailoring testing programs for 
each chemical in an informed way, as well as 
supporting risk assessment. Computational 
methods also hold promise in other areas of 
the risk assessment process, particularly in esti-
mating the extent of variability in response in 
the human population, in supporting more 
sophisticated aggregate exposure assessment, 
and in providing a pragmatic approach to eval-
uating the risks posed by cumulative exposure 
to mixtures of compounds.
It was clear that these are still early days for 
the application of computational toxicology to 
risk assessment and chemical regulation, but 
there are already examples where application 
of computational toxicology is taking place. 
For example, relational databases that can be 
searched by chemical substructure are being 
used to make predictions about the toxicity 
of new chemicals based on their similarity to 
chemicals for which the toxicity potential has 
been evaluated. The U.S. EPA has recently 
evaluated the use of toxicogenomics data to 
support its risk assessment approaches for 
phthalate esters (U.S. EPA/Office of Research 
and Development/National Center for 
Environmental Assessment 2009). Because the 
desire for computational approaches exceeds 
the pace at which practical applications are 
coming online, many of the regulatory agency 
participants at the meeting expressed frustration Rusyn and Daston
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that their expectations were not being met. 
It will be important in the future to manage 
these expectations and to make sure that there 
are enough short-term applications so that the 
long-term research programs, which are neces-
sary to meet the full potential of computational 
toxicology, can be supported.
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